Abstract
The present invention relates to a T-cell receptor comprising: a) an alpha chain comprising an amino acid sequence as set forth in SEQ ID No.1 or a functional equivalent thereof; and/or b) a beta chain comprising an amino acid sequence as set forth in SEQ ID No.2 or a functional equivalent thereof; as well as uses thereof including in the treatment of an EBV+ tumour.
| Original language | English |
|---|---|
| Patent number | WO/2017/085471 |
| IPC | C07K 14/725,A61K 38/17 |
| Priority date | 16/11/15 |
| Publication status | Published - 26 May 2017 |